Project Grant R21AG085052
Award Date
8/1/24
Completion Date
7/31/27
Dollars Obligated
$158K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45221, USA
Similar Awards
This $3,109,079 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research at the University of California, Riverside to investigate the role of traumatic brain injury (TBI) across the lifespan in the development of Alzheimer's disease and related dementias (ADRD). The project will use a closed head injury (CHI) TBI mouse model to examine how ADRD risk factors, such as the APOE4 gene and amyloid-beta, interact with TBI at different life stages...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award provides $274,855 to Mito-Biotherapeutics, Inc. to develop a novel fusion protein construct (NFP) that can cross the blood-brain barrier and deliver a therapeutic payload to repair mitochondrial DNA damage in neurons following traumatic brain injury (TBI). The project aims to attenuate neurological damage and prevent the progression of TBI to neurodegenerative diseases like...
This $587,521 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will support research on the use of near infrared (NIR) light to modulate mitochondrial function as a therapy for traumatic brain injury (TBI). The research aims to: (1) explore the molecular mechanisms of neurotrauma and therapeutic NIR on mitochondrial dynamics and...
This $192,737 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Texas Tech University Health Sciences Center (TTUHSC) aims to investigate the mechanisms by which traumatic brain injury (TBI) leads to vascular and neuronal dysfunction, which can contribute to the development of age-related diseases. The key objectives are to determine: Whether inhibiting the interaction between prostaglandins and the biomarker UCHL1 can mitigate TBI-induced blood-brain...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research at the Augusta University Research Institute, Inc. (doing business as Georgia Health Sciences) to investigate the mechanisms linking traumatic brain injury (TBI) to subsequent neurodegeneration and dementia. The $1,975,262 award will support a 3-year study...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $102,948.00 to Case Western Reserve University to investigate the link between traumatic brain injury (TBI), hematopoietic stem cell dysfunction, chronic neurodegeneration, and Alzheimer's disease (AD). The key objectives are to assess how acute TBI induces changes to...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $3,770,822 will fund research conducted by the University of Pittsburgh to investigate the relationship between epigenetic aging and patient outcomes after severe traumatic brain injury (TBI). The study aims to determine if accelerated epigenetic aging, as measured by DNA methylation, is linked to poorer recovery and increased risk of Alzheimer's disease and related dementias in TBI patients....
This federal Project Grant award, valued at $3,102,638.00 and spanning August 15, 2024 to July 31, 2027, was provided by the National Institute on Aging (CFDA 93.866 - Aging Research) to The Trustees of the University of Pennsylvania. The grant aims to develop novel gyrencephalic animal models that can recapitulate the complex neuropathological and clinical features associated with traumatic brain injury (TBI)-induced Alzheimer's disease and related dementias (ADRD). The project will evaluate...
This $7.72 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866). The Seattle Institute for Biomedical and Clinical Research will define the role of post-traumatic brain injury sleep disruption and glymphatic dysfunction in the development of Alzheimer's disease and chronic traumatic encephalopathy neuropathology. Over three years, the grantee and three sub-awardees will...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $628,133 Project Grant (CFDA 93.853) to Rutgers, The State University to study the "Metabolic Mechanisms of Recovery in Mild TBI" from September 1, 2024 to July 31, 2028. The research aims to determine if activating the CYPIN protein can promote functional recovery after mild traumatic brain injury (TBI) in mice. This builds on previous work identifying CYPIN as a key molecule regulating methionine levels and...